Market Place
Sourcing Support
Phoenix PharmaLabs’ Lead Compound, PPL-138, Offers Promise as PTSD/AUD Treatment
14 Sep 2023 //
BUSINESSWIRE
Phoenix Awarded $8.7 Million Grant from NIDA to Study Compound
06 Oct 2022 //
BUSINESSWIRE
Phoenix Successfully Completes Second Oversubscribed Netcapital Offering Raising
22 Jun 2021 //
BUSINESSWIRE
Phoenix Strengthens its Position as a Developer of Next Generation Pain Pharma
05 Jan 2021 //
BUSINESSWIRE
Phoenix PharmaLabs Announces New Investment Offering with Netcapital
21 Dec 2020 //
BUSINESSWIRE
BridgeBio Pharma’s Phoenix Tissue Repair Provides Updates t RDEB
13 May 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.